Clinical Trial

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty

Name: Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty — clinical trial record (NCT04319848)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TE-EK

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Assessment of safety and efficacy of tissue-engineered corneal endothelial graft material generated using cultured human corneal endothelial cells for tissue-engineered endothelial keratoplasty (TE-EK).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2020-03-22.

Trial Details

NCT Number	NCT04319848
Lead Sponsor	Singapore Eye Research Institute
Conditions	Mild to Moderate Corneal Endothelial Decompensation, Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Post-surgical Corneal Decompensation (Irreversible)
Enrollment	30 participants
Start Date	2017-12-01
Primary Completion	2027-12 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2025-09-12